A wide variety of human diseases are underpinned by inflammatory abnormalities. Tissue damage as a consequence of impaired control of the elaborate system of immune cells and mediators can also contribute to autoimmunity and non-immune diseases such as atherosclerosis and various cancers.
At Cerba Research, access to demographically rich data and industry-leading laboratories across the globe propels the development of more progressive biomarker strategies to assist in the characterization of the mechanisms that contribute to inflammatory and autoimmune diseases — and determine novel targets for therapeutic intervention.
Image Credit: Cerba Research
64% of Cerba Research’s autoimmune disease trials have led to the FDA approval of drugs.
Inflammation
Clients can boost research in inflammatory conditions with Cerba Research’s extensive range of test services and research assistance associated with:
- Allergies and respiratory disorders
- Autoimmune diseases
- Biomarkers
- Genetics
- Immune monitoring
- Pathogenesis
Autoimmune diseases
Research into autoimmunity takes advantage of a multidimensional approach.
Genetic testing/NGS
Together with infections and other exposures, genes have a central role in disease development.
Diagnosis and development
Tissue diagnosis and routine testing establish pathology and the course of the disease.
Immune monitoring
Evaluate response to treatment by following up on the immune cell status via flow cytometry.
Biomarker testing
Design and track serum markers for both the prognosis and diagnosis of autoimmune diseases.
For other appropriate techniques, please evaluate Cerba’s immuno-oncology offerings.
As a partner, Cerba Research helps clients to create new, life-changing therapies for patients around the world. Cerba helps to transform the face of clinical development.
About Cerba Research
For over 35 years, Cerba Research has been setting the industry standard for exemplary clinical trial conduct. Today, across five continents, with a focus on precision medicine, we are changing the paradigm of the central lab’s role in complex clinical research.
From protocol inception through development and to market, our passionate experts deliver the highest quality specialized and personalized laboratory and diagnostic solutions. Partner with us for the most efficient strategy to actualize your biotech and pharmaceutical products sooner and improve the lives of patients worldwide.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.